MetaCap

GlucoTrack Inc. Company Profile

NASDAQ: GCTKHealth CareMedical/Dental InstrumentsUSD

1.03-0.08 (-7.21%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

GlucoTrack at a glance

GlucoTrack Inc. (NASDAQ: GCTK) is a Medical/Dental Instruments company in the Health Care sector headquartered in Rutherford, NJ. GlucoTrack is led by Mr. Erik C. Emerson and employs about 15 people. At a market capitalization of $1.0 million, it is considered a small-cap company.

Its SEC Central Index Key (CIK) is 0001506983, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does GlucoTrack do?

GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

Business description based on the company's public filings.

Company information

Legal name
GlucoTrack Inc.
Ticker
NASDAQ: GCTK
Industry
Medical/Dental Instruments
CEO
Mr. Erik C. Emerson
Employees
15
Headquarters
301 Route 17 North, Rutherford, NJ, United States
Phone
201 842 7715
SEC CIK
0001506983
Latest annual report
10-K · Mar 30, 2026

Companies similar to GlucoTrack

GCTK peer companies
CompanyPrice% ChgMarket capCompare
PFSAProfusa Inc.1.42-4.70%$860.02Kvs GCTK
NXGLNexGel Inc0.2003+33.53%$97.62Kvs GCTK
MMEDVMiniMed Group Inc.19.50-1.02%—vs GCTK
XAIRBeyond Air Inc.2.25-2.60%$2.21Mvs GCTK
VJETFlyte Aviation Inc.1.14+12.87%$2.40Mvs GCTK
IVFINVO Fertility Inc.0.7275-2.28%$3.35Mvs GCTK
ADGMAdagio Medical Holdings Inc0.130.00%$3.53Mvs GCTK
BJDXBluejay Diagnostics Inc.0.8239+1.02%$3.68Mvs GCTK

Related